TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells.
about
Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognitionThe role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells.Copy number alteration and uniparental disomy analysis categorizes Japanese papillary thyroid carcinomas into distinct groups.Cell surface-bound TIMP3 induces apoptosis in mesenchymal Cal78 cells through ligand-independent activation of death receptor signaling and blockade of survival pathways.Identification of thyroid tumor cell vulnerabilities through a siRNA-based functional screeningPericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury.Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral CancerEZH2 is required for breast and pancreatic cancer stem cell maintenance and can be used as a functional cancer stem cell reporter.Complex temporal changes in TGFβ oncogenic signaling drive thyroid carcinogenesis in a mouse modelThe pseudogene TUSC2P promotes TUSC2 function by binding multiple microRNAs.Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progressionMolecular Aberrance in Papillary Thyroid Microcarcinoma Bearing High Aggressiveness: Identifying a "Tibetan Mastiff Dog" From Puppies.Differential TIMP3 expression affects tumor progression and angiogenesis in melanomas through regulation of directionally persistent endothelial cell migration.EZH2 regulates cancer cell migration through repressing TIMP-3 in non-small cell lung cancer.Tissue inhibitor of metalloproteinases-3 transfer suppresses malignant behaviors of colorectal cancer cells.MiR-221 Exacerbate Cell Proliferation and Invasion by Targeting TIMP3 in Papillary Thyroid Carcinoma.IL-32 gamma reduces lung tumor development through upregulation of TIMP-3 overexpression and hypomethylation.The Association of BRAF V600E Mutation With Tissue Inhibitor of Metalloproteinase-3 Expression and Clinicopathological Features in Papillary Thyroid Cancer.
P2860
Q33761979-63677514-CD4C-4622-9D2D-19FC6FBD7863Q34137728-4EBD84F5-706A-4C08-8AC6-548617ADE90EQ34257114-E1200C7E-12AF-4F09-8246-8352DC78B8D2Q34876809-5DF42C65-26F1-4AB2-B66A-0A4EB066C55EQ35797331-D8DBD57D-F599-4FE6-8C06-6E7971BA187EQ35917508-5EF0720E-6BDE-4D42-AE6B-16A666F7CACEQ36299328-FDFFF6CB-F5F8-4BFD-BC8E-8532CD01BD04Q36861707-5EB2D6FB-1FF1-4AEC-A873-70C62EC081F0Q37205853-A04D05DF-D8D0-4278-88CA-4BBEB615B97BQ37497280-375FEF22-0D9D-468D-92B4-46BF54DF1044Q37612861-40884D11-A4CB-4CFA-87C8-CDD4BE5D654FQ38721735-F2E3ABBF-62B9-40FE-9B25-F2F00C046219Q39063857-1B6F6A0F-3F65-49C1-9221-DB1917828398Q39077650-550C86FC-FFC1-4FE2-87B9-8C59DBE8B9B6Q39265667-10A43464-4337-4DBD-AD80-D7C11B3022E8Q42067988-49C3F3D1-31D5-4008-B557-3C4D931EFB0BQ53082211-E4DAF0F9-EEB3-4B79-9DE6-FDA4E489864EQ55021417-EAFA5C8C-04DA-49FE-9B6F-D79D97B22E8F
P2860
TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells.
@en
TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells.
@nl
type
label
TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells.
@en
TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells.
@nl
prefLabel
TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells.
@en
TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells
@en
P2093
E Radaelli
F Formelli
M G Borrello
M G Vizioli
S Pagliardini
P2860
P2888
P304
P356
10.1038/ONC.2011.18
P407
P577
2011-02-21T00:00:00Z